Annual obesity costs may soar to £58bn
New detailed datasets will more accurately map out the impact of obesity throughout UK
Read More
Author: John Pinching
First RSV vaccine trial for infants offers significant results
The phase 3 MELODY study reveals that nirsevimab vaccine reduces lower respiratory tract infections
Read More
Previously untreatable lung cancer patients offered new therapy
NICE document recommends Amgen’s Lumykras (sotorasib) to treat non-small-cell lung cancer
Read More
Clinical jobs increase as R&D and lab roles experience record growth
The post-Brexit landscape has witnessed an exponential boom in life science careers
Read More
Novartis’ Kesimpta trial provides positive results for MS patients
MS patients given boost by results of study into Kesimpta – a self-administered treatment with potential to improve lives
Read More
